EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives

Raluca Pele iD, Gabriel Marc iD, Cristina Mogoșan iD, Anamaria Apan iD, Ioana Ionuț, Brîndușa Tiperciuc iD, Cristina Moldovan iD, Cătălin Araniciu iD, Ilioara Oniga iD, Adrian Pîrnău, Laurian Vlase iD, Ovidiu Oniga

Molecules · 2024

DOI: 10.3390/molecules29091951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Raluca Pele und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cl…. Hauptthemen laut MEDLINE: Anticonvulsants, Seizures, Receptors, GABA-A, Pentylenetetrazole. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, MCID through the "Nucleu" Programme within the National Plan for Research, Development and Innovation 2022-2027 and through the Installations and Special Objec…, “Iuliu Hațieganu” University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two series, “a” and “b”, each consisting of nine chemical compounds, with 2,3-disubstituted quinazolin-4(3H)-one scaffold, were synthesized and evaluated for their anticonvulsant activity. They were investigated as dual potential positive allosteric modulators of the GABAA receptor at the benzodiazepine binding site and inhibitors of carbonic anhydrase II. Quinazolin-4(3H)-one derivatives were evaluated in vivo (D1–3 = 50, 100, 150 mg/kg, administered intraperitoneally) using the pentylenetetrazole (PTZ)-induced seizure model in mice, with phenobarbital and diazepam, as reference anticonvulsant agents. The in silico studies suggested the compounds act as anticonvulsants by binding on the allosteric site of GABAA receptor and not by inhibiting the carbonic anhydrase II, because the ligands-carbonic anhydrase II predicted complexes were unstable in the molecular dynamics simulations. The mechanism targeting GABAA receptor was confirmed through the in vivo flumazenil antagonism assay. The pentylenetetrazole experimental anticonvulsant model indicated that the tested compounds, 1a–9a and 1b–9b, present a potential anticonvulsant activity. The evaluation, considering the percentage of protection against PTZ, latency until the onset of the first seizure, and reduction in the number of seizures, revealed more favorable results for the “b” series, particularly for compound 8b.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsSeizuresReceptors, GABA-APentylenetetrazoleAnimalsMiceQuinazolinonesMolecular Docking SimulationMaleStructure-Activity RelationshipMolecular Dynamics SimulationComputer SimulationDisease Models, AnimalMolecular StructureAllosteric Site

Stichwörter der Autor:innen

anticonvulsant activitymolecular dockingmolecular dynamicsquinazolin-4(3H)-one

Substanzen

AnticonvulsantsReceptors, GABA-APentylenetetrazoleQuinazolinones

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
  • Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 6A Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
  • Department of Therapeutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 12 Ion Creangă, 400010 Cluj-Napoca, Romania.
  • Department of Pharmacognosy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 12 Ion Creangă, 400010 Cluj-Napoca, Romania.
  • National Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Street, 400293 Cluj-Napoca, Romania.
  • Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.

ORCID-Profile: Raluca Pele, Gabriel Marc, Cristina Mogoșan, Anamaria Apan, Brîndușa Tiperciuc, Cristina Moldovan, Cătălin Araniciu, Ilioara Oniga, Laurian Vlase

Förderung

  • Iuliu Hațieganu University of Medicine and Pharmacy
  • MCID through the "Nucleu" Programme within the National Plan for Research, Development and Innovation 2022-2027 and through the Installations and Special Objec…
  • “Iuliu Hațieganu” University of Medicine and Pharmacy
  • MCID

Zitieren

APA

Pele, R., Marc, G., Mogoșan, C., Apan, A., Ionuț, I., Tiperciuc, B., Moldovan, C., Araniciu, C., Oniga, I., Pîrnău, A., Vlase, L., & Oniga, O. (2024). Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives. Molecules. https://doi.org/10.3390/molecules29091951

Vancouver

Pele R, Marc G, Mogoșan C, Apan A, Ionuț I, Tiperciuc B, et al. Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives. Molecules. 2024. doi:10.3390/molecules29091951

BibTeX
@article{Pele2024,
  author = {Pele, Raluca and Marc, Gabriel and Mogoșan, Cristina and Apan, Anamaria and Ionuț, Ioana and Tiperciuc, Brîndușa and Moldovan, Cristina and Araniciu, Cătălin and Oniga, Ilioara and Pîrnău, Adrian and Vlase, Laurian and Oniga, Ovidiu},
  title = {Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29091951}
}
Kostenlos starten →